International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Fibromyalgia

Author(s): Oberlander Kevin

Issue: Jan/Feb 2000 - Compounding for Pain Management
View All Articles in Issue

Page(s): 21-23

Download in electronic PDF format for $75

Abstract: Fibromyalgia is a collection of symptoms with an unknown cause. In this article, the author focuses on symptoms and treatment regimen (dietary recommendations, exercise, sleep, stress, nutritional support and topical treatments). A sidebar shows the body’s tender points and describes their location. The author concludes that if individuals and their physicians are willing to be persistent and integrate conventional practice with the tools of the compounding pharmacist, the patient will improve.

Related Keywords: aching muscles, amitriptyline, anti-inflammatories, baclofen, carbamazepine, cyclobenzaprine, depression, diclofenac, diet, exercise, fatigue, fibromyalgia syndrome, fibrositis, ibuprofen, ketamine, ketoprofen, lidacaine, muscular pain, nutritional support, piroxicam, PLO, polymyalgia, sleep, sleep deprivation, stress, tender points, transdermal gels

Related Categories: PAIN MANAGEMENT

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Fibromyalgia Oberlander Kevin	Jan/Feb 2000 Pg. 21-23
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 512
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Allen Loyd V Jr	May/Jun 2017 Pg. 234
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel Allen Loyd V Jr	May/Jun 2011 Pg. 245
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Allen Loyd V Jr	Mar/Apr 2011 Pg. 157
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K	Mar/Apr 2004 Pg. 101-105
Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules Allen Loyd V Jr	May/Jun 2020 Pg. 227
Women's Health Book Reviews Reed-Kane Dana	Sep/Oct 1999 Pg. 357-359
The Role of Sex Hormones on Fibromyalgia Pain Mediators Bramwell Bethany L	May/Jun 2010 Pg. 193-199
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 513
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 514
Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2008 Pg. 540
Topical Ketoprofen for Fibromyalgia Manuel Julie, Ford Gina	Nov/Dec 1998 Pg. 433
The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia Cote Brianna, Ross Bethany, Fortner Jeff, Rao Deepa	May/Jun 2018 Pg. 252-256
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Goodwin Donald A, Fuhram L Clifton	Nov/Dec 1999 Pg. 496-500
Feline Urologic Syndrome and Diet Formulation Long Scott F	Sep/Oct 1999 Pg. 366-367
Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO Allen Loyd V Jr	Mar/Apr 2000 Pg. 133
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H	Mar/Apr 2018 Pg. 172-175
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Trimble John, Light Bob	May/Jun 2016 Pg. 250-256
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future Rabi Joseph	Mar/Apr 2016 Pg. 107-113
Return to Top